These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25952022)

  • 21. LC-MS/MS progress in newborn screening.
    Lehotay DC; Hall P; Lepage J; Eichhorst JC; Etter ML; Greenberg CR
    Clin Biochem; 2011 Jan; 44(1):21-31. PubMed ID: 20709048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
    Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
    Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests.
    la Marca G; Malvagia S; Casetta B; Pasquini E; Donati MA; Zammarchi E
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S395-404. PubMed ID: 18956250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method.
    Hubbard WC; Moser AB; Liu AC; Jones RO; Steinberg SJ; Lorey F; Panny SR; Vogt RF; Macaya D; Turgeon CT; Tortorelli S; Raymond GV
    Mol Genet Metab; 2009 Jul; 97(3):212-20. PubMed ID: 19423374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of mass spectrometry to analyze dried blood spots.
    Wagner M; Tonoli D; Varesio E; Hopfgartner G
    Mass Spectrom Rev; 2016; 35(3):361-438. PubMed ID: 25252132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.
    Piraud M; Pettazzoni M; Lavoie P; Ruet S; Pagan C; Cheillan D; Latour P; Vianey-Saban C; Auray-Blais C; Froissart R
    J Inherit Metab Dis; 2018 May; 41(3):457-477. PubMed ID: 29556840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.
    Theda C; Gibbons K; Defor TE; Donohue PK; Golden WC; Kline AD; Gulamali-Majid F; Panny SR; Hubbard WC; Jones RO; Liu AK; Moser AB; Raymond GV
    Mol Genet Metab; 2014 Jan; 111(1):55-7. PubMed ID: 24268529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency.
    Viau KS; Ernst SL; Pasquali M; Botto LD; Hedlund G; Longo N
    Mol Genet Metab; 2013 Nov; 110(3):255-62. PubMed ID: 24071436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.
    Lee S; Clinard K; Young SP; Rehder CW; Fan Z; Calikoglu AS; Bali DS; Bailey DB; Gehtland LM; Millington DS; Patel HS; Beckloff SE; Zimmerman SJ; Powell CM; Taylor JL
    JAMA Netw Open; 2020 Jan; 3(1):e1920356. PubMed ID: 32003821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inborn errors of metabolism and expanded newborn screening: review and update.
    Mak CM; Lee HC; Chan AY; Lam CW
    Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tandem mass spectrometry as screening for inborn errors of metabolism].
    Campos H D
    Rev Med Chil; 2011 Oct; 139(10):1356-64. PubMed ID: 22286738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
    Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tandem mass spectrometry-based multiplex assays for α-mannosidosis and fucosidosis.
    Kumar AB; Hong X; Yi F; Wood T; Gelb MH
    Mol Genet Metab; 2019 Jul; 127(3):207-211. PubMed ID: 31235216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a fast LC-MS/MS protocol for combined measurement of six LSDs on dried blood spot in a newborn screening program.
    Scolamiero E; Casetta B; Malvagia S; Tanigawa T; Forni G; Funghini S; Mura M; Raspini F; Poggiali S; la Marca G
    J Pharm Biomed Anal; 2019 Feb; 165():135-140. PubMed ID: 30530130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn screening for sickle cell disorders using tandem mass spectrometry: three years' experience of using a protocol to detect only the disease states.
    Moat SJ; Rees D; George RS; King L; Dodd A; Ifederu A; Ramgoolam T; Hillier S
    Ann Clin Biochem; 2017 Sep; 54(5):601-611. PubMed ID: 28656815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Advances for Newborn Screening of Inborn Errors of Metabolism by Capillary Electrophoresis-Mass Spectrometry (CE-MS).
    Shanmuganathan M; Britz-McKibbin P
    Methods Mol Biol; 2019; 1972():139-163. PubMed ID: 30847789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First experience with a fully automated extraction system for simultaneous on-line direct tandem mass spectrometric analysis of amino acids and (acyl-)carnitines in a newborn screening setting.
    Fingerhut R; Silva Polanco ML; Silva Arevalo Gde J; Swiderska MA
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):965-73. PubMed ID: 24623702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study to estimate incidence of guanidinoacetate methyltransferase deficiency in newborns by direct sequencing of the GAMT gene.
    Mercimek-Mahmutoglu S; Pop A; Kanhai W; Fernandez Ojeda M; Holwerda U; Smith D; Loeber JG; Schielen PC; Salomons GS
    Gene; 2016 Jan; 575(1):127-31. PubMed ID: 26319512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry.
    Tesorero R; Janda J; Hörster F; Feyh P; Mütze U; Hauke J; Schwarz K; Kunz JB; Hoffmann GF; Okun JG
    PLoS One; 2023; 18(3):e0283024. PubMed ID: 36897914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system.
    Navarrete-Martínez JI; Limón-Rojas AE; Gaytán-García MJ; Reyna-Figueroa J; Wakida-Kusunoki G; Delgado-Calvillo MDR; Cantú-Reyna C; Cruz-Camino H; Cervantes-Barragán DE
    Mol Genet Metab; 2017 May; 121(1):16-21. PubMed ID: 28302345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.